Fifty410 tirzepatide is compounded GLP-1 therapy sold through a telehealth platform. Learn pricing, dosing, safety, and how it compares to brand options.
Fifty410 tirzepatide is compounded tirzepatide dispensed through the Fifty410 telehealth platform, which connects patients to licensed providers and a partner compounding pharmacy. It contains the same active drug as Zepbound and Mounjaro, but it is not FDA-approved and it is not the brand product. Because federal compounding rules for tirzepatide tightened in 2025, availability, pricing, and legality vary — so it pays to understand exactly what you are buying before you pay.
What "Fifty410 Tirzepatide" Means
Tirzepatide is a dual GIP and GLP-1 receptor agonist approved by the FDA as Zepbound for weight management and Mounjaro for type 2 diabetes. It is given as a once-weekly subcutaneous injection.
Compounded tirzepatide is prepared by a licensed compounding pharmacy, usually as a multi-dose vial used with insulin syringes. Compounded drugs are not FDA-approved, and the FDA does not review them for safety, effectiveness, or manufacturing quality the way it reviews brand-name products. The name is sometimes written as fifty 410 tirzepatide, but it refers to the same platform and the same compounded medication.
Fifty410 is one of several telehealth companies that built GLP-1 programs around compounded tirzepatide and compounded semaglutide. After the FDA declared the tirzepatide shortage resolved, it set compliance deadlines for compounders to stop producing copies of the approved product, which reshaped how platforms like Fifty410 can dispense the drug.
Fifty410 tirzepatide is a compounded prescription, not a generic version of Zepbound — there is no FDA-approved generic tirzepatide in the United States.
How the Fifty410 Tirzepatide Process Works
- Online intake: You complete a health questionnaire covering medical history, current medications, prior weight-loss attempts, and goals.
- Provider review: A licensed clinician reviews your information and decides whether tirzepatide is appropriate. This usually takes one to three business days.
- Pharmacy fulfillment: If approved, the prescription goes to a partner compounding pharmacy and ships, often within three to ten business days.
- Titration and monitoring: You start at a low dose and increase slowly, checking in with the provider through the platform's messaging system.
- Refills: Most plans are billed monthly or in multi-month bundles, and your price can change when your dose changes.
No telehealth platform can guarantee a prescription. Providers may decline treatment or recommend a different medication based on your history, and legitimate programs will not ship medication before a clinician reviews your intake.
Fifty410 Tirzepatide Cost Compared With Other Options
Compounded GLP-1 pricing changes often, so treat any figure as a snapshot rather than a locked-in rate. Historically, compounded tirzepatide has run a few hundred dollars per month, well below the list price of brand Zepbound pens.
| Option | Active ingredient | FDA-approved | Typical monthly cost | Notes |
|---|---|---|---|---|
| Fifty410 compounded tirzepatide | Tirzepatide (compounded) | No | $200–$500, varies by dose and plan | Requires provider approval; subject to state and federal compounding rules |
| Brand Zepbound or Mounjaro | Tirzepatide | Yes | $350–$1,000+ with insurance or savings programs | Pens or single-dose vials; coverage varies widely |
| Compounded semaglutide | Semaglutide (compounded) | No | $150–$400 | Same compounding restrictions apply |
| Brand Wegovy or Ozempic | Semaglutide | Yes | $500–$1,000+ | Wegovy is approved for weight management; insurance is often required |
Cost is only one variable. Also weigh whether the program includes lab work, provider access, dose adjustments, and a refund policy if the medication never arrives.
Tirzepatide Dosage: What a Standard Schedule Looks Like
The standard tirzepatide dosage starts at 2.5 mg once weekly for four weeks, then increases to 5 mg weekly. Providers can raise the dose by 2.5 mg every four weeks, up to a maximum of 15 mg per week.
- 2.5 mg — starting dose, usually four weeks
- 5 mg — first maintenance step
- 7.5 mg and 10 mg — common mid-range doses
- 12.5 mg and 15 mg — highest approved doses
Compounded vials are often more concentrated than brand pens, so the number of units you draw is not the same as the milligram dose. Confirm the conversion with your prescriber or pharmacist before injecting.
Never increase a dose on your own. Faster titration is one of the most common reasons people end up in the emergency room with severe nausea, vomiting, and dehydration.
Side Effects and Safety Considerations
Common side effects include nausea, diarrhea, constipation, vomiting, belching, fatigue, and injection-site reactions. Most are mild and ease as the body adjusts, but they can be severe.
Serious risks include pancreatitis, gallbladder disease, bowel obstruction, kidney injury from dehydration, and hypoglycemia when combined with insulin or sulfonylureas. Tirzepatide carries a boxed warning for thyroid C-cell tumors and is contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN2 syndrome.
Tirzepatide is not for use during pregnancy and is not recommended while breastfeeding. Rapid weight loss can also cause muscle loss and hair thinning, which is one reason people research lipo-c and tirzepatide or ask about tirzepatide with l-carnitine as an addition to their plan. Evidence that either combination improves outcomes is limited, and neither replaces adequate protein intake and resistance training.
Compounded products add another layer of uncertainty: dosing errors, inconsistent potency, and contamination have all been reported with compounded GLP-1s. Verify that the pharmacy is licensed in your state and holds a 503A or 503B designation.
How Tirzepatide Compares to Semaglutide and Newer Drugs
Many people searching for tirzepatide vs semaglutide which is better for weight loss are comparing average trial results. In the head-to-head SURMOUNT-5 trial, tirzepatide produced greater average weight loss than semaglutide, but individual response, side effects, and cost often matter more than group averages.
Researchers are also studying amylin-based drugs. Early data on cagrilintide vs tirzepatide points to a different mechanism, and cagrilintide is not FDA-approved for weight loss. Anyone comparing compounded options should weigh the difference between a drug with completed phase 3 trials and one still under investigation.
The safest approach is to review your goals, budget, and health history with a licensed clinician rather than choosing a product from a search result alone.
RELATED PEPTIDE TOPICTirzepatide peptide researchFrequently Asked Questions
Is Fifty410 tirzepatide FDA-approved?
No. Compounded tirzepatide is not FDA-approved, and the FDA does not review compounded drugs for safety, effectiveness, or quality the way it reviews brand-name products such as Zepbound. It contains the same active ingredient but is prepared by a compounding pharmacy rather than the brand manufacturer.
How much does Fifty410 tirzepatide cost per month?
Pricing varies by dose, plan length, and pharmacy, and it changes frequently. Compounded tirzepatide has typically run a few hundred dollars per month, which is below the list price of brand pens. Confirm the current price, what is included, and the refill policy with the platform before you pay.
Is compounded tirzepatide still available in the United States?
Availability has narrowed since the FDA declared the tirzepatide shortage resolved and set deadlines for compounders to stop making copies of the approved product. Some pharmacies can still compound on a patient-specific basis, and state rules differ. Verify legality and pharmacy licensing in your state before ordering.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.